Literature DB >> 29156055

Analysis of an ADTKD family with a novel frameshift mutation in MUC1 reveals characteristic features of mutant MUC1 protein.

Satoko Yamamoto1, Jun-Ya Kaimori1,2, Takuji Yoshimura3, Tomoko Namba1, Atsuko Imai4,5, Kaori Kobayashi4,6, Ryoichi Imamura7, Naotsugu Ichimaru2, Kazuto Kato8, Akihiro Nakaya4, Shiro Takahara2, Yoshitaka Isaka1.   

Abstract

BACKGROUND: Medullary cystic kidney disease Type 1 is an autosomal dominant tubulointerstitial kidney disease (ADTKD). Recently, mucin 1 (MUC1) was identified as a causal gene of medullary cystic kidney disease (ADTKD-MUC1). However, the MUC1 mutation was found to be a single cytosine insertion in a single copy of the GC-rich variable number of tandem repeats (VNTRs), which are very difficult to analyze by next-generation sequencing. To date, other mutations have not been detected in ADTKD-MUC1, and the mutant MUC1 protein has not been analyzed because of the difficulty of genetically modifying the VNTR sequence.
METHODS: We conducted whole-exome analyses of an ADTKD family by next-generation sequencing. We also performed histopathological analyses of a renal biopsy from a pedigree family member. We constructed a mutant protein expression vector based on the patient genome sequence and characterized the nature of the mutant protein.
RESULTS: We found a novel frameshift mutation before the VNTR in the MUC1 gene. The resulting mutant MUC1 protein had a very similar amino acid sequence and predicted 3D structure to the previously reported mutant protein. Notably, the recombinant mutant MUC1 protein was trapped in the cytoplasm and appeared to self-aggregate. The patient native mutant protein was also found in urine exosomes.
CONCLUSIONS: This novel frameshift mutation in the MUC1 gene and consequent mutant protein may contribute to the future discovery of the pathophysiology of ADTKD-MUC1. The mutant MUC1 protein in urine exosomes may be used for non-DNA-related diagnosis.
© The Author 2017. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Entities:  

Keywords:  ADTKD; ADTKD-MUC1; MUC1; VNTR; frameshift mutation

Mesh:

Substances:

Year:  2017        PMID: 29156055     DOI: 10.1093/ndt/gfx083

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  9 in total

1.  MUC1 Makes Me Miserable.

Authors:  Daniel P Gale; Robert Kleta
Journal:  J Am Soc Nephrol       Date:  2018-08-17       Impact factor: 10.121

2.  Evaluation of Genetic Kidney Diseases in Living Donor Kidney Transplantation: Towards Precision Genomic Medicine in Donor Risk Assessment.

Authors:  Yasar Caliskan; Brian Lee; Adrian Whelan; Fadee Abualrub; Krista L Lentine; Arksarapuk Jittirat
Journal:  Curr Transplant Rep       Date:  2022-03-16

3.  Biallelic Expression of Mucin-1 in Autosomal Dominant Tubulointerstitial Kidney Disease: Implications for Nongenetic Disease Recognition.

Authors:  Karl X Knaup; Thomas Hackenbeck; Bernt Popp; Johanna Stoeckert; Andrea Wenzel; Maike Büttner-Herold; Frederick Pfister; Markus Schueler; Didem Seven; Annette M May; Jan Halbritter; Hermann-Josef Gröne; André Reis; Bodo B Beck; Kerstin Amann; Arif B Ekici; Michael S Wiesener
Journal:  J Am Soc Nephrol       Date:  2018-07-26       Impact factor: 10.121

4.  Noninvasive Immunohistochemical Diagnosis and Novel MUC1 Mutations Causing Autosomal Dominant Tubulointerstitial Kidney Disease.

Authors:  Martina Živná; Kendrah Kidd; Anna Přistoupilová; Veronika Barešová; Mathew DeFelice; Brendan Blumenstiel; Maegan Harden; Peter Conlon; Peter Lavin; Dervla M Connaughton; Hana Hartmannová; Kateřina Hodaňová; Viktor Stránecký; Alena Vrbacká; Petr Vyleťal; Jan Živný; Miroslav Votruba; Jana Sovová; Helena Hůlková; Victoria Robins; Rebecca Perry; Andrea Wenzel; Bodo B Beck; Tomáš Seeman; Ondřej Viklický; Sylvie Rajnochová-Bloudíčková; Gregory Papagregoriou; Constantinos C Deltas; Seth L Alper; Anna Greka; Anthony J Bleyer; Stanislav Kmoch
Journal:  J Am Soc Nephrol       Date:  2018-07-02       Impact factor: 10.121

5.  Single molecule real time sequencing in ADTKD-MUC1 allows complete assembly of the VNTR and exact positioning of causative mutations.

Authors:  Andrea Wenzel; Janine Altmueller; Arif B Ekici; Bernt Popp; Kurt Stueber; Holger Thiele; Alois Pannes; Simon Staubach; Eduardo Salido; Peter Nuernberg; Richard Reinhardt; André Reis; Patrick Rump; Franz-Georg Hanisch; Matthias T F Wolf; Michael Wiesener; Bruno Huettel; Bodo B Beck
Journal:  Sci Rep       Date:  2018-03-08       Impact factor: 4.379

Review 6.  Emerging Role of Clinical Genetics in CKD.

Authors:  Prasad Devarajan; Glenn M Chertow; Katalin Susztak; Adeera Levin; Rajiv Agarwal; Peter Stenvinkel; Arlene B Chapman; Bradley A Warady
Journal:  Kidney Med       Date:  2022-02-11

7.  Detecting MUC1 Variants in Patients Clinicopathologically Diagnosed With Having Autosomal Dominant Tubulointerstitial Kidney Disease.

Authors:  Eri Okada; Naoya Morisada; Tomoko Horinouchi; Hideki Fujii; Takayuki Tsuji; Masayoshi Miura; Hideyuki Katori; Masashi Kitagawa; Kunio Morozumi; Takanobu Toriyama; Yuki Nakamura; Ryuta Nishikomori; Sadayuki Nagai; Atsushi Kondo; Yuya Aoto; Shinya Ishiko; Rini Rossanti; Nana Sakakibara; China Nagano; Tomohiko Yamamura; Shingo Ishimori; Joichi Usui; Kunihiro Yamagata; Kazumoto Iijima; Toshiyuki Imasawa; Kandai Nozu
Journal:  Kidney Int Rep       Date:  2022-01-04

8.  Plasma Mucin-1 (CA15-3) Levels in Autosomal Dominant Tubulointerstitial Kidney Disease due to MUC1 Mutations.

Authors:  Petr Vylet'al; Kendrah Kidd; Hannah C Ainsworth; Drahomíra Springer; Alena Vrbacká; Anna Přistoupilová; Rebecca P Hughey; Seth L Alper; Niall Lennon; Steven Harrison; Maegan Harden; Victoria Robins; Abbigail Taylor; Lauren Martin; Katrice Howard; Ibrahim Bitar; Carl D Langefeld; Veronika Barešová; Hana Hartmannová; Kateřina Hodaňová; Tomáš Zima; Martina Živná; Stanislav Kmoch; Anthony J Bleyer
Journal:  Am J Nephrol       Date:  2021-06-07       Impact factor: 3.754

9.  Autosomal dominant tubulointerstitial kidney disease (ADTKD) in Ireland.

Authors:  S Cormican; D M Connaughton; C Kennedy; S Murray; M Živná; S Kmoch; N K Fennelly; P O'Kelly; K A Benson; E T Conlon; G Cavalleri; C Foley; B Doyle; A Dorman; M A Little; P Lavin; K Kidd; A J Bleyer; P J Conlon
Journal:  Ren Fail       Date:  2019-11       Impact factor: 2.606

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.